Ledger.Open graph →
SEC Form D · filed January 6, 2022

Phi Therapeutics, Inc

Offering
$2.0M
Sold
$660K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Yug Varma · San Francisco, CAExec · Director · PromoterMaria S. Cho · San Francisco, CADirector · PromoterJoan D. Clarke · Prince George, VAExec · Director · PromoterRudy L. Hawkins · Prince George, VADirector · PromoterJun Li · Foshan City,Guangdong Province, IsraelDirectorJoshua Feast · Boston, MADirector · PromoterMark Midle · Boston, MAExec · Director · PromoterJun Li · Kirkland, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗